NEW YORK (GenomeWeb News) – Rosetta Genomics will work with the Rabin Medical Center in Israel to develop microRNA-based tests for women’s health, the company said today.
The company plans to use microRNA biomarkers to develop “a wide range of diagnostic and prognostic tests” in oncology, gynecology, and obstetrics, the Rehovot, Israel-based company said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.